UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

Journal of the American College of Cardiology, 2002-04, Vol.39 (7), p.1214-1219

2002

Volltextzugriff (PDF)

A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen

Annals of the American Thoracic Society, 2022-04, Vol.19 (4), p.594-602

2022

Volltextzugriff (PDF)

Beyond conventional therapy: role of pulse steroids in bleomycin induced lung injury

Respiratory care, 2014-01, Vol.59 (1), p.e9-e12

2014

Volltextzugriff (PDF)

STEMI associated with SARS-CoV-2 infection and the use of ECMO as a potential therapeutic approach in addition to the PCI

Oxford Medical Case Reports, 2021-03, Vol.2021 (3), p.omaa148

2021

Volltextzugriff (PDF)

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension

The American journal of cardiology, 1999-08, Vol.84 (4), p.481-484

1999

Volltextzugriff (PDF)

Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension

The American journal of cardiology, 2003-04, Vol.91 (8), p.1033-1037

2003

Volltextzugriff (PDF)

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

The lancet respiratory medicine, 2020-01, Vol.8 (1), p.25-33

2020

Volltextzugriff (PDF)

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

The New England journal of medicine, 2014-05, Vol.370 (22), p.2083-2092

2014

Volltextzugriff (PDF)

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

The lancet respiratory medicine, 2020-08, Vol.8 (8), p.775-785

2020

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis

Chest, 2020-08, Vol.158 (2), p.637-645

2020

Volltextzugriff (PDF)

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial

Annals of internal medicine, 2013-05, Vol.158 (9), p.641

2013

Volltextzugriff (PDF)

Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

American journal of respiratory and critical care medicine, 2024-03, Vol.209 (6), p.647-669

2024

Volltextzugriff (PDF)

Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

American journal of respiratory and critical care medicine, 2024-08, Vol.210 (4), p.424-434

2024

Volltextzugriff (PDF)

Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (5), p.380

2024

Volltextzugriff (PDF)

Safety and yield of transbronchial biopsy in mechanically ventilated patients

Critical care medicine, 1997-03, Vol.25 (3), p.440-446

1997

Volltextzugriff (PDF)

OPEN-LABEL DOSE-ESCALATION DATA FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF PULSED, INHALED NITRIC OXIDE (INO) IN SUBJECTS AT RISK OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY FIBROSIS (PH-PF) ON LONG TERM OXYGEN THERAPY

Chest, 2019-10, Vol.156 (4), p.A2273-A2275

2019

Volltextzugriff (PDF)

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

The lancet respiratory medicine, 2019-09, Vol.7 (9), p.771-779

2019

Volltextzugriff (PDF)

Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension

Circulation (New York, N.Y.), 1999-06, Vol.99 (25), p.3266-3271

1999

Volltextzugriff (PDF)

Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial

Pulmonary therapy, 2021-12, Vol.7 (2), p.471-486

2021

Volltextzugriff (PDF)

Nephrobronchial Fistula and Lung Abscess Resulting From Nephrolithiasis and Pyelonephritis

Chest, 1995-10, Vol.108 (4), p.1166-1168

1995

Volltextzugriff (PDF)

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

The American journal of medicine, 1993-09, Vol.95 (3), p.273-278

1993

Volltextzugriff (PDF)

The Washington University— Barnes Hospital Experience With Lung Transplantation

JAMA : the journal of the American Medical Association, 1991-10, Vol.266 (14), p.1943

Trulock, Elbert P.

1991

Volltextzugriff (PDF)

The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures

Chest, 1992-10, Vol.102 (4), p.1049-1054

1992

Volltextzugriff (PDF)

PULMONARY COMPLICATIONS OF LIVER TRANSPLANTATION

Clinics in chest medicine, 1996-03, Vol.17 (1), p.99-114

1996

Volltextzugriff (PDF)

A review of the respiratory effects of smoking cocaine

The American journal of medicine, 1989-12, Vol.87 (6), p.664-668

1989

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen

Beyond conventional therapy: role of pulse steroids in bleomycin induced lung injury

STEMI associated with SARS-CoV-2 infection and the use of ECMO as a potential therapeutic approach in addition to the PCI

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension

Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial

Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial

Safety and yield of transbronchial biopsy in mechanically ventilated patients

OPEN-LABEL DOSE-ESCALATION DATA FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF PULSED, INHALED NITRIC OXIDE (INO) IN SUBJECTS AT RISK OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY FIBROSIS (PH-PF) ON LONG TERM OXYGEN THERAPY

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension

Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial

Nephrobronchial Fistula and Lung Abscess Resulting From Nephrolithiasis and Pyelonephritis

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

The Washington University— Barnes Hospital Experience With Lung Transplantation

The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures

PULMONARY COMPLICATIONS OF LIVER TRANSPLANTATION

A review of the respiratory effects of smoking cocaine

Suchergebnisse filtern